Skip to main content
Clinical Trials/KCT0007951
KCT0007951Completed未知

The effect of gender on the ED50 of remimazolam for loss of consciousness in adult patients co-administered with remifentanil infusion

Ajou University Hospital0 sites60 target enrollmentStarted: TBDLast updated:

Trial Snapshot

Phase
未知
Status
Completed
Sponsor
Enrollment
60

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional Study

Eligibility Criteria

Ages
19(Year) to 60(Year) (—)
Sex
All

Inclusion Criteria

  • Adult patients aged 19-60 years with ASA score 1 or 2 scheduled for general anesthesia

Exclusion Criteria

  • BMI > 30 kg/m2
  • History of allergies to benzodiazepines
  • History of allergies to opioids
  • Patients unable to response on verbal command
  • Use of opioids, alcohol, benzodiazeplines and over-the-counter sleep aids

Investigators

Sponsor
Ajou University Hospital

Similar Trials